Health Canada inspection
Pfizer Asia Pacific Pte Ltd.: Health Canada inspection of Apr 15, 2019
Health Canada · GMP · rating C
Key facts
| Establishment | Pfizer Asia Pacific Pte Ltd. |
|---|---|
| City | Singapore |
| Country | Singapore |
| Program | GMP |
| Start date | Apr 10, 2019 |
| End date | Apr 15, 2019 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.